CN102940845B - Traditional Chinese medicine composition for treating gastritis as well as preparation method and application of composition - Google Patents
Traditional Chinese medicine composition for treating gastritis as well as preparation method and application of composition Download PDFInfo
- Publication number
- CN102940845B CN102940845B CN201210524123.6A CN201210524123A CN102940845B CN 102940845 B CN102940845 B CN 102940845B CN 201210524123 A CN201210524123 A CN 201210524123A CN 102940845 B CN102940845 B CN 102940845B
- Authority
- CN
- China
- Prior art keywords
- parts
- fructus
- chinese medicine
- gastritis
- medicine composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention provides a traditional Chinese medicine composition for treating gastritis. The traditional Chinese medicine composition is prepared from the following raw materials in parts by weight: 5-15 parts of pinellia, 10-20 parts of elecampane, 15-25 parts of loosestrife, 15-25 parts of forsythia, 10-20 parts of amomum cardamomum, 10-20 parts of rhizoma corydalis, 10-20 parts of toosendan fruit, 10-20 parts of herba hyperici japonica, 15-25 parts of coptis, 15-25 parts of tuckahoe, 15-25 parts of radix bupleuri, 5-10 parts of bighead atractylodes rhizome, 15-25 parts of fructus aurantii, 10-20 parts of cortex magnoliae officinalis, 15-25 parts of fiveleaf akebia fruit, 10-20 parts of areca, 15-25 parts of angelica, 10-20 parts of gizzard pepsin, 15-25 parts of concha arcae and 15-25 parts of liquorice. The traditional Chinese medicine composition has the functions of resolving damp with aromatics, regulating qi and invigorating stomach so as to treat the gastritis. The invention further discloses a preparation method and an application.
Description
Technical field
The present invention relates to technical field of Chinese medicines, be specifically related to a kind of Chinese medicine composition that is used for the treatment of gastritis and its preparation method and application.
Background technology
In gastritis, chronic atrophic gastritis refers to that the chronic gastritis that atrophic changes has occurred gastric mucosa, and chronic atrophic gastritis can be divided into again many kitchen ranges atrophic gastritis and the large class of autoimmunity gastritis two.Chronic atrophic gastritis is common disease of stomach.The hobby of arteriosclerosis, stomach Insufficience of blood flow, cigarette,wine and tea etc. all easily damage the barrier function of gastric mucosa and cause chronic atrophic gastritis.When chronic atrophic gastritis, gastric mucosa atrophy and to be replaced by the epithelial cell of intestinal be that intestinalization is raw; Inflammation continue develop, Growth of Cells is not true to type, between become; Even hyperplasia and carcinogenesis.Chronic atrophic gastritis clinical manifestation only the indigestion symptom such as moves back for Abdeminal pain, belch, stomach poor appetite, and sometimes because gastric anti-pernicious anemia factor is destroyed, vitamin B12 malabsorption can cause anemia.Endoscopy and biopsy are the only resources of making a definite diagnosis chronic atrophic gastritis.Gastroscope Diagnosis should comprise the degree of diseased region, atrophy degree, intestinalization life and atypical hyperplasia.The mucosa that naked eyes are line-of-sighted observation chronic atrophic gastritis is pale or greyish white more, and pleat attenuates or be smooth.The mucosa that mucosa can show Chronic Atrophic Gastritis Patients red and white, serious is dispersed in white speckle.The feature that under mucosa, exposed vessel is chronic atrophic gastritis, can see red netted small artery or blood capillary, and serious chronic atrophic gastritis has epithelial hyperplasia to form fine particle or compared with greater tubercle as seen.Also there is mucosal erosion, bleeding.Mucosa Biopsy pathology is mainly body of gland atrophy in various degree, disappearance, replaces gland metaplasia or intestinal gland metaplasia, and interstitial inflammatory infiltration is remarkable.Chronic atrophic gastritis is positioned at the body of gland of gastric mucosa because of reasons such as inflammatory infiltrations, body of gland atrophy or disappearance.Its sickness rate of chronic atrophic gastritis is showed increased with the increase at age.Main manifestations is that epigastrium is glutted, discomfort or pain, obvious after the meal, simultaneously with other indigestion symptoms as belch, acid regurgitation, feel sick, vomiting, inappetence etc.People are in the urgent need to a kind of effective, own Chinese medicine composition that is confirmed the treatment chronic atrophic gastritis that can play good result by most people.
Summary of the invention
Goal of the invention: in order to address the above problem, the object of the present invention is to provide a kind of Chinese medicine composition that is used for the treatment of gastritis and its preparation method and application.
Technical scheme: the object of the invention is to realize by following scheme:
Be used for the treatment of a Chinese medicine composition for gastritis, it is prepared by the raw material of following parts by weight: Rhizoma Pinelliae 5-15 part, Radix Aucklandiae 10-20 part, Herba Lysimachiae 15-25 part, Fructus Forsythiae 15-25 part, Fructus Amomi Rotundus 10-20 part, Rhizoma Corydalis 10-20 part, Fructus Toosendan 10-20 part, Herba Hyperici Japonici 10-20 part, Rhizoma Coptidis 15-25 part, Poria 15-25 part, Radix Bupleuri 15-25 part, Rhizoma Atractylodis Macrocephalae 5-10 part, Fructus Aurantii 15-25 part, Cortex Magnoliae Officinalis 10-20 part, Fructus Akebiae 15-25 part, Semen Arecae 10-20 part, Radix Angelicae Sinensis 15-25 part, Endothelium Corneum Gigeriae Galli 10-20 part, Concha Arcae 15-25 part, Radix Glycyrrhizae 15-25 part.
The above-mentioned Chinese medicine composition that is used for the treatment of gastritis, it is prepared by the raw material of following parts by weight: 10 parts of the Rhizoma Pinelliaes, 15 parts of the Radix Aucklandiae, 20 parts of Herba Lysimachiaes, 20 parts of Fructus Forsythiaes, 15 parts of Fructus Amomi Rotunduss, 15 parts of Rhizoma Corydalis, 15 parts of Fructus Toosendans, 15 parts of Herba Hyperici Japonici, 20 parts of Rhizoma Coptidis, 20 parts, Poria, 20 parts of Radix Bupleuri, 8 parts of the Rhizoma Atractylodis Macrocephalaes, 20 parts of Fructus Aurantiis, 15 parts of Cortex Magnoliae Officinalis, 20 parts of Fructus Akebiaes, 15 parts of Semen Arecaes, 20 parts of Radix Angelicae Sinensis, 15 parts of Endothelium Corneum Gigeriae Galli, 20 parts of Concha Arcaes, 20 parts, Radix Glycyrrhizae.
The above-mentioned Chinese medicine composition that is used for the treatment of gastritis, described raw material adds adjuvant and makes oral liquid, tablet, capsule or granule after extracting.
The above-mentioned Chinese medicine composition that is used for the treatment of gastritis, described adjuvant is one or more of dextrin, lactose, starch, sucrose, glucose, microcrystalline Cellulose, mannose, methylcellulose, hydroxypropyl cellulose, carboxymethyl cellulose and stevioside.
The preparation method of the above-mentioned Chinese medicine composition that is used for the treatment of gastritis, it comprises the steps: to get the Rhizoma Pinelliae, the Radix Aucklandiae, Herba Lysimachiae, Fructus Forsythiae, Fructus Amomi Rotundus, Rhizoma Corydalis, Fructus Toosendan, Herba Hyperici Japonici, Rhizoma Coptidis, Poria, Radix Bupleuri, the Rhizoma Atractylodis Macrocephalae, Fructus Aurantii, Cortex Magnoliae Officinalis, Fructus Akebiae, Semen Arecae, Radix Angelicae Sinensis, Endothelium Corneum Gigeriae Galli, Concha Arcae, licorice medicinal materials merges, decoct with water twice, collecting decoction, the extractum that while being evaporated to 65 DEG C, relative density is 1.15-1.20, adding ethanol makes to reach 75-85% containing the percent by volume of alcohol amount, stir, leave standstill, filter, when filtrate decompression is concentrated into 65 DEG C, relative density is 1.25-1.30, and reclaim ethanol, obtain concentrated solution, concentrated solution is added water and adjuvant is mixed with oral liquid, or by dry concentrated solution spraying, add adjuvant and make capsule, tablet, granule.
The preparation method of the above-mentioned Chinese medicine composition that is used for the treatment of gastritis, in step, decocting condition is: add water for the first time as the 8-12 of medical material weight doubly measures, decoct 1-2h, add water for the second time as the 6-10 of medical material weight doubly measures, decoct 1-2h.
The preparation method of the above-mentioned Chinese medicine composition that is used for the treatment of gastritis, in step, spraying drying condition is: inlet temperature is 100-120 DEG C, leaving air temp is 80-90 DEG C, temperature of charge is 70-90 DEG C, and atomizing pressure is 0.2-0.4 MPa, and spray velocity is 5-10ml/s.
The above-mentioned Chinese medicine composition that is used for the treatment of gastritis is in the application of preparing in the medicine for the treatment of gastritis.
Beneficial effect:
1, from theory of Chinese medical science, the Rhizoma Pinelliae, the Radix Aucklandiae, Herba Lysimachiae, Fructus Forsythiae, Fructus Amomi Rotundus, Rhizoma Corydalis, Fructus Toosendan, Herba Hyperici Japonici removing dampness by means of aromatics in we, for monarch drug, the stomach invigorating of regulating the flow of vital energy of Rhizoma Coptidis, Poria, Radix Bupleuri, the Rhizoma Atractylodis Macrocephalae, Fructus Aurantii, Cortex Magnoliae Officinalis, Fructus Akebiae, Semen Arecae, is ministerial drug, and Radix Angelicae Sinensis, Endothelium Corneum Gigeriae Galli, Concha Arcae, Radix Glycyrrhizae are adjuvant, all medicines are harmonious, play altogether removing dampness by means of aromatics, the digestion promoting function of regulating the flow of vital energy, is used for the treatment of gastritis.
2, Formulation of the present invention is reasonable, and compatibility is rigorous, through long-term clinical verification, determined curative effect.
3, the present invention consists of Chinese crude drug, and Herba Hyperici Japonici is the herb of Garcinia maingayii Herba Hyperici Japonici, and Fructus Akebiae is the fruit of BENTONG section plant Caulis Akebiae, threeleaf akebia, white BENTONG, and all the other are pharmacopeia kind, have no side effect, and low price.
Detailed description of the invention
Form by the following examples, foregoing of the present invention is described in further detail again, but this should be interpreted as to the scope of the above-mentioned theme of the present invention only limits to following example, all technology realizing based on foregoing of the present invention all belong to scope of the present invention.
1, Preparation Example
Embodiment 1: get Rhizoma Pinelliae 5g, Radix Aucklandiae 20g, Herba Lysimachiae 15g, Fructus Forsythiae 25g, Fructus Amomi Rotundus 10g, Rhizoma Corydalis 20g, Fructus Toosendan 10g, Herba Hyperici Japonici 20g, Rhizoma Coptidis 15g, Poria 25g, Radix Bupleuri 15g, Rhizoma Atractylodis Macrocephalae 5g, Fructus Aurantii 25g, Cortex Magnoliae Officinalis 10g, Fructus Akebiae 25g, Semen Arecae 10g, Radix Angelicae Sinensis 25g, Endothelium Corneum Gigeriae Galli 10g, Concha Arcae 25g, Radix Glycyrrhizae 15g medical material merges, and decocts with water twice, adds water for the first time as 8 times of amounts of medical material weight, decocts 1h, adds water for the second time as 6 times of amounts of medical material weight, decocts 1h, collecting decoction, 0.07MPa, while being evaporated to 65 DEG C at 60-70 DEG C, relative density is 1.10, adds 95% (v/v) ethanol and makes to reach 85% (v/v) containing alcohol amount, stirs, and leaves standstill 24 hours, and decompression filtrate recycling ethanol is also concentrated, and filtrate is at 0.07MPa, when under 65 DEG C of conditions, concentrating under reduced pressure becomes to 65 DEG C, relative density is 1.30, and spraying is dry, and (condition is that inlet temperature is 120 DEG C, and leaving air temp is 100 DEG C, and temperature of charge is 90 DEG C, and atomizing pressure is 0.4 MPa, and spray velocity is 10ml/s.), add starch, mix homogeneously, with the moistening of appropriate 80% (v/v) ethanol, soft material processed, crosses 30 mesh sieves and granulates, in 70 ~ 80 DEG C dry, with 60 mesh sieve granulate, tabletting, sugar coating, subpackage, outer package, censorship is qualified, obtains tablet.
Embodiment 2: get Rhizoma Pinelliae 10g, Radix Aucklandiae 15g, Herba Lysimachiae 20g, Fructus Forsythiae 20g, Fructus Amomi Rotundus 15g, Rhizoma Corydalis 15g, Fructus Toosendan 15g, Herba Hyperici Japonici 15g, Rhizoma Coptidis 20g, Poria 20g, Radix Bupleuri 20g, Rhizoma Atractylodis Macrocephalae 8g, Fructus Aurantii 20g, Cortex Magnoliae Officinalis 15g, Fructus Akebiae 20g, Semen Arecae 15g, Radix Angelicae Sinensis 20g, Endothelium Corneum Gigeriae Galli 15g, Concha Arcae 20g, Radix Glycyrrhizae 20g medical material merges, and decocts with water twice, adds water for the first time as 10 times of amounts of medical material weight, decocts 1.5h, adds water for the second time as 8 times of amounts of medical material weight, decocts 1.5h, collecting decoction, 0.07MPa, while being evaporated to 65 DEG C at 60-70 DEG C, relative density is 1.15, adds 95% (v/v) ethanol and makes to reach 75% (v/v) containing alcohol amount, stirs, and leaves standstill 24 hours, and decompression filtrate recycling ethanol is also concentrated, and filtrate is at 0.07MPa, when under 65 DEG C of conditions, concentrating under reduced pressure becomes to 65 DEG C, relative density is 1.25, and spraying is dry, and (condition is that inlet temperature is 100 DEG C, and leaving air temp is 80 DEG C, and temperature of charge is 80 DEG C, and atomizing pressure is 0.2 MPa, and spray velocity is 5ml/s.), adding dextrin etc., dry granulation, crosses 60 mesh sieves, packs No. 1 capsule into and gets final product to obtain capsule.
Embodiment 3: get Rhizoma Pinelliae 15g, Radix Aucklandiae 10g, Herba Lysimachiae 25g, Fructus Forsythiae 15g, Fructus Amomi Rotundus 20g, Rhizoma Corydalis 10g, Fructus Toosendan 20g, Herba Hyperici Japonici 10g, Rhizoma Coptidis 25g, Poria 15g, Radix Bupleuri 25g, Rhizoma Atractylodis Macrocephalae 5g, Fructus Aurantii 25g, Cortex Magnoliae Officinalis 10g, Fructus Akebiae 25g, Semen Arecae 10g, Radix Angelicae Sinensis 25g, Endothelium Corneum Gigeriae Galli 10g, Concha Arcae 25g, Radix Glycyrrhizae 15g medical material merges, and decocts with water twice, adds water for the first time as 12 times of amounts of medical material weight, decocts 2h, adds water for the second time as 10 times of amounts of medical material weight, decocts 2h, collecting decoction, 0.07MPa, while being evaporated to 65 DEG C at 60-70 DEG C, relative density is 1.15, adds 95% (v/v) ethanol and makes to reach 75% (v/v) containing alcohol amount, stirs, and leaves standstill 24 hours, and decompression filtrate recycling ethanol is also concentrated, and filtrate is at 0.07MPa, when under 65 DEG C of conditions, concentrating under reduced pressure becomes to 65 DEG C, relative density is 1.25, and spraying is dry, and (condition is that inlet temperature is 110 DEG C, and leaving air temp is 85 DEG C, and temperature of charge is 85 DEG C, and atomizing pressure is 0.3 MPa, and spray velocity is 7.5ml/s.), add above-mentioned Benexate Hydrochloride, pulverize, then add suitable lactose, with the moistening of appropriate 80% (v/v) ethanol, soft material processed, cross 14 mesh sieves and granulate, 50-80 DEG C is dry, and 60 order granulate, obtain granule.
Embodiment 4: get Rhizoma Pinelliae 10g, Radix Aucklandiae 15g, Herba Lysimachiae 20g, Fructus Forsythiae 20g, Fructus Amomi Rotundus 15g, Rhizoma Corydalis 15g, Fructus Toosendan 15g, Herba Hyperici Japonici 15g, Rhizoma Coptidis 20g, Poria 20g, Radix Bupleuri 20g, Rhizoma Atractylodis Macrocephalae 8g, Fructus Aurantii 20g, Cortex Magnoliae Officinalis 15g, Fructus Akebiae 20g, Semen Arecae 15g, Radix Angelicae Sinensis 20g, Endothelium Corneum Gigeriae Galli 15g, Concha Arcae 20g, Radix Glycyrrhizae 20g medical material merges, decoct with water twice, add water for the first time as 10 times of amounts of medical material weight, decoct 1.5h, add water for the second time as 8 times of amounts of medical material weight, decoct 1.5h, collecting decoction, 0.07MPa, while being evaporated to 65 DEG C at 60-70 DEG C, relative density is 1.15, adding 95% (v/v) ethanol makes to reach 75% (v/v) containing alcohol amount, stir, leave standstill 24 hours, decompression filtrate recycling ethanol is also concentrated, filtrate is at 0.07MPa, when under 65 DEG C of conditions, concentrating under reduced pressure becomes to 65 DEG C, relative density is 1.25, add water and sucrose, be prepared into oral liquid.
2. the pharmacodynamic study that affects on laboratory animal
Experimental agents: the preparation method preparation by above-mentioned oral liquid embodiment: i.e. Rhizoma Pinelliae 10g, Radix Aucklandiae 15g, Herba Lysimachiae 20g, Fructus Forsythiae 20g, Fructus Amomi Rotundus 15g, Rhizoma Corydalis 15g, Fructus Toosendan 15g, Herba Hyperici Japonici 15g, Rhizoma Coptidis 20g, Poria 20g, Radix Bupleuri 20g, Rhizoma Atractylodis Macrocephalae 8g, Fructus Aurantii 20g, Cortex Magnoliae Officinalis 15g, Fructus Akebiae 20g, Semen Arecae 15g, Radix Angelicae Sinensis 20g, Endothelium Corneum Gigeriae Galli 15g, Concha Arcae 20g, Radix Glycyrrhizae 20g medical material merges, decoct with water twice, add water for the first time as 10 times of amounts of medical material weight, decoct 1.5h, add water for the second time as 8 times of amounts of medical material weight, decoct 1.5h, collecting decoction, 0.07MPa, while being evaporated to 65 DEG C at 60-70 DEG C, relative density is 1.15, adding 95% (v/v) ethanol makes to reach 75% (v/v) containing alcohol amount, stir, leave standstill 24 hours, decompression filtrate recycling ethanol is also concentrated, filtrate is at 0.07MPa, when under 65 DEG C of conditions, concentrating under reduced pressure becomes to 65 DEG C, relative density is 1.25, add water and sucrose, be prepared into oral liquid, obtain 20 of oral liquid finished products.Specification: 10ml/ props up (being equivalent to containing crude drug 16g)
Dosage: according to " the dose,equivalent ratio table of converting by surface between humans and animals ", every day, 70 kilograms of people's consumption was 48g, every day, the consumption of every 200g rat was 48*0.018=0.86g, because every oral liquid 10ml is 16g containing crude drug amount, the consumption that is every rat is 0.54ml, therefore determine low dose of every gavage 0.5ml oral liquid, middle dosage and high dose be gavage 1ml and 2ml respectively, every day, the oral liquid of every 200g rat oral gavage was respectively 0.8g containing crude drug amount, 1.6g, 3.2g, by rat body weight, low dosage, middle dosage and high dose are respectively 4g crude drug amount/kg, 8g crude drug amount/kg and 16g crude drug amount/kg.
60 of the clean level of laboratory animal: SD rats, male, body weight 180～210g, Shanghai Si Laike Experimental Animal Center provides.
Experiment reagent: vitacoenzyme tablet, the Hebei pharmaceutcal corporation, Ltd of being surrounded by sea, lot number 20110611; Sodium salicylate, Jiangsu Yonghua Fine Chemical Co., Ltd., lot number 090709; 95% medical alcohol, Nanjing Ning Shi chemical reagent company limited, lot number 20071128; Ammonia, Chengdu Ke Long chemical reagent factory, lot number 20080622; Motilin, gastrin radioimmunological kit, Beijing Fu Rui bio-engineering corporation.
Experimentation: at random 60 rats are divided into 6 groups, be respectively: dosage group, the heavy dose of group of the present invention in blank group, model group, vitacoenzyme group, small dose group of the present invention, the present invention, every group of l0 only, modeling is except the normal raising of blank group, other 5 groups adopt 2% sodium salicylate and 30% ethanol mixed solution, set time every day gavage, before and after gavage, water 1h, 10mL/kg are prohibited in fasting; Rat is freely drunk 0.05% ammonia; Coordinate irregular diet method, every feed 2d, fasting 1d.Before modeling finishes, randomly draw two and do gastric mucosa pathological histology inspection, confirm to occur the atrophy of gastric mucosa body of gland, intestinal and atypical hyperplasia etc., stop modeling medicine, enters treatment stage.Modeling amounts to 17 weeks.Treatment amounts to 4 weeks.After end, rat fasting 24h, 1.5% pentobarbital intraperitoneal injection of anesthesia is cut off the otch of an about 2.5cm under xiphoid-process along hunter's line, carefully mention stomach, in pylorus and the stitching thread ligation of duodenum joint portion, avoids blood vessel.After sewing-up cut, send back in cage.After 3h, then ligation cardia, esophagus lower end and duodenum near-end cut off respectively, extract full stomach, wash away surperficial blood stains, blot with filter paper, put in culture dish and cut off gastral cavity along greater gastric curvature, collect gastric juice in centrifuge tube, with the centrifugal 20min of 3000rpm, draw supernatant, carry out gastric analysis, the special capillary tube method of wheat is surveyed pepsin, and result is as follows:
Table 1 the present invention is on pepsin impact research (X ± SD)
Note: with model group comparison, * P<0.05; * P<0.01
Experiment conclusion: the present invention can improve pepsin activity in gastritis rat model gastric juice, demonstrates gastritis is had to certain therapeutical effect.
Claims (6)
1. a Chinese medicine composition that is used for the treatment of gastritis, is characterized in that, it is prepared by the raw material of following parts by weight: Rhizoma Pinelliae 5-15 part, Radix Aucklandiae 10-20 part, Herba Lysimachiae 15-25 part, Fructus Forsythiae 15-25 part, Fructus Amomi Rotundus 10-20 part, Rhizoma Corydalis 10-20 part, Fructus Toosendan 10-20 part, Herba Hyperici Japonici 10-20 part, Rhizoma Coptidis 15-25 part, Poria 15-25 part, Radix Bupleuri 15-25 part, Rhizoma Atractylodis Macrocephalae 5-10 part, Fructus Aurantii 15-25 part, Cortex Magnoliae Officinalis 10-20 part, Fructus Akebiae 15-25 part, Semen Arecae 10-20 part, Radix Angelicae Sinensis 15-25 part, Endothelium Corneum Gigeriae Galli 10-20 part, Concha Arcae 15-25 part, Radix Glycyrrhizae 15-25 part, preparation method comprises the steps: to get the Rhizoma Pinelliae, the Radix Aucklandiae, Herba Lysimachiae, Fructus Forsythiae, Fructus Amomi Rotundus, Rhizoma Corydalis, Fructus Toosendan, Herba Hyperici Japonici, Rhizoma Coptidis, Poria, Radix Bupleuri, the Rhizoma Atractylodis Macrocephalae, Fructus Aurantii, Cortex Magnoliae Officinalis, Fructus Akebiae, Semen Arecae, Radix Angelicae Sinensis, Endothelium Corneum Gigeriae Galli, Concha Arcae, licorice medicinal materials merges, and decocts with water twice, collecting decoction, the extractum that while being evaporated to 65 DEG C, relative density is 1.15-1.20, adds ethanol and makes to reach 75-85% containing the percent by volume of alcohol amount, stirs, leave standstill, filter, when filtrate decompression is concentrated into 65 DEG C, relative density is 1.25-1.30, and reclaims ethanol, obtain concentrated solution, concentrated solution is added water and adjuvant is mixed with oral liquid, or by dry concentrated solution spraying, add adjuvant and make capsule, tablet, granule.
2. the Chinese medicine composition that is used for the treatment of gastritis according to claim 1, it is characterized in that, it is prepared by the raw material of following parts by weight: 10 parts of the Rhizoma Pinelliaes, 15 parts of the Radix Aucklandiae, 20 parts of Herba Lysimachiaes, 20 parts of Fructus Forsythiaes, 15 parts of Fructus Amomi Rotunduss, 15 parts of Rhizoma Corydalis, 15 parts of Fructus Toosendans, 15 parts of Herba Hyperici Japonici, 20 parts of Rhizoma Coptidis, 20 parts, Poria, 20 parts of Radix Bupleuri, 8 parts of the Rhizoma Atractylodis Macrocephalaes, 20 parts of Fructus Aurantiis, 15 parts of Cortex Magnoliae Officinalis, 20 parts of Fructus Akebiaes, 15 parts of Semen Arecaes, 20 parts of Radix Angelicae Sinensis, 15 parts of Endothelium Corneum Gigeriae Galli, 20 parts of Concha Arcaes, 20 parts, Radix Glycyrrhizae.
3. the Chinese medicine composition that is used for the treatment of gastritis according to claim 1, it is characterized in that, described adjuvant is one or more of dextrin, lactose, starch, sucrose, glucose, microcrystalline Cellulose, mannose, methylcellulose, hydroxypropyl cellulose, carboxymethyl cellulose and stevioside.
4. the Chinese medicine composition that is used for the treatment of gastritis according to claim 1, is characterized in that, in preparation method step, decocting condition is: add water for the first time and doubly measure for the 8-12 of medical material weight, decoct 1-2h, add water for the second time as the 6-10 of medical material weight doubly measures, decoct 1-2h.
5. the Chinese medicine composition that is used for the treatment of gastritis according to claim 1, it is characterized in that, in preparation method step, spraying drying condition is: inlet temperature is 100-120 DEG C, leaving air temp is 80-90 DEG C, temperature of charge is 70-90 DEG C, and atomizing pressure is 0.2-0.4 MPa, and spray velocity is 5-10ml/s.
6. described in claim 1, be used for the treatment of the Chinese medicine composition of gastritis in the application of preparing in the medicine for the treatment of gastritis.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201210524123.6A CN102940845B (en) | 2012-12-08 | 2012-12-08 | Traditional Chinese medicine composition for treating gastritis as well as preparation method and application of composition |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201210524123.6A CN102940845B (en) | 2012-12-08 | 2012-12-08 | Traditional Chinese medicine composition for treating gastritis as well as preparation method and application of composition |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN102940845A CN102940845A (en) | 2013-02-27 |
| CN102940845B true CN102940845B (en) | 2014-08-20 |
Family
ID=47723905
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201210524123.6A Expired - Fee Related CN102940845B (en) | 2012-12-08 | 2012-12-08 | Traditional Chinese medicine composition for treating gastritis as well as preparation method and application of composition |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102940845B (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104306544A (en) * | 2014-11-09 | 2015-01-28 | 朱海燕 | Traditional Chinese medicine composition for treating chronic atrophic gastritis as well as preparation method and application thereof |
| CN106138987A (en) * | 2015-04-13 | 2016-11-23 | 周海腾 | A kind of Chinese medicine oral liquid treating gastritis |
Citations (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1110592A (en) * | 1994-10-21 | 1995-10-25 | 孟灵源 | Pill for treating hepatogastric vital energy stagnation type chronic superficial, atrophic gastritis |
| CN101062212A (en) * | 2007-06-07 | 2007-10-31 | 巩振宏 | Chinese medicinal herb composition for treating gastritis |
| CN101647940A (en) * | 2009-08-22 | 2010-02-17 | 冯少军 | Traditional Chinese medicine for treating gastritis and preparation method thereof |
| CN101721574A (en) * | 2008-11-03 | 2010-06-09 | 任风辉 | Traditional Chinese medicine formula for treating gastritis |
| CN101972443A (en) * | 2010-10-18 | 2011-02-16 | 朱新华 | Chinese medicinal formula for treating chronic gastritis |
| CN102038894A (en) * | 2009-10-15 | 2011-05-04 | 张红旗 | Prescription for curing bile regurgitational gastritis |
| CN102178887A (en) * | 2011-05-16 | 2011-09-14 | 汤炳显 | Traditional Chinese medicine for treating gastropathy |
| CN102274466A (en) * | 2011-08-15 | 2011-12-14 | 荣成市商贸城卫生所 | Chinese medicinal composition for treating gastritis |
| CN102319336A (en) * | 2011-09-21 | 2012-01-18 | 万燕丽 | Traditional Chinese medicine for treating gastritis |
| CN102552851A (en) * | 2012-02-03 | 2012-07-11 | 河南中医学院 | Traditional Chinese medicine for treating chronic gastrointestinal diseases |
-
2012
- 2012-12-08 CN CN201210524123.6A patent/CN102940845B/en not_active Expired - Fee Related
Patent Citations (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1110592A (en) * | 1994-10-21 | 1995-10-25 | 孟灵源 | Pill for treating hepatogastric vital energy stagnation type chronic superficial, atrophic gastritis |
| CN101062212A (en) * | 2007-06-07 | 2007-10-31 | 巩振宏 | Chinese medicinal herb composition for treating gastritis |
| CN101721574A (en) * | 2008-11-03 | 2010-06-09 | 任风辉 | Traditional Chinese medicine formula for treating gastritis |
| CN101647940A (en) * | 2009-08-22 | 2010-02-17 | 冯少军 | Traditional Chinese medicine for treating gastritis and preparation method thereof |
| CN102038894A (en) * | 2009-10-15 | 2011-05-04 | 张红旗 | Prescription for curing bile regurgitational gastritis |
| CN101972443A (en) * | 2010-10-18 | 2011-02-16 | 朱新华 | Chinese medicinal formula for treating chronic gastritis |
| CN102178887A (en) * | 2011-05-16 | 2011-09-14 | 汤炳显 | Traditional Chinese medicine for treating gastropathy |
| CN102274466A (en) * | 2011-08-15 | 2011-12-14 | 荣成市商贸城卫生所 | Chinese medicinal composition for treating gastritis |
| CN102319336A (en) * | 2011-09-21 | 2012-01-18 | 万燕丽 | Traditional Chinese medicine for treating gastritis |
| CN102552851A (en) * | 2012-02-03 | 2012-07-11 | 河南中医学院 | Traditional Chinese medicine for treating chronic gastrointestinal diseases |
Also Published As
| Publication number | Publication date |
|---|---|
| CN102940845A (en) | 2013-02-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102940846B (en) | Traditional Chinese medicine composition for treating atrophic gastritis as welln as preparation method and application of composition | |
| CN102258680B (en) | Chinese medicinal composition for reliving physical fatigue and preparation method and use thereof | |
| CN102935187A (en) | Traditional Chinese medicinal composition for treating chronic atrophic gastritis, and preparation method and application thereof | |
| CN103656410A (en) | Traditional Chinese medicine preparation for treating cough and preparation method thereof | |
| CN102940845B (en) | Traditional Chinese medicine composition for treating gastritis as well as preparation method and application of composition | |
| CN102406714B (en) | Pharmaceutical composition favorable for defaecation and preparation method thereof | |
| CN104001004A (en) | Traditional Chinese medicine composition for curing fractures and osteoporosis and preparation method and application thereof | |
| CN103845633B (en) | It is a kind of to treat Chinese medicine composition of canker sore and preparation method thereof | |
| CN102935177B (en) | Traditional Chinese medicine composition for treating sjogren syndrome as well as preparation method and application thereof | |
| CN102274332B (en) | Process for preparing Chinese medicinal powder for treating peptic ulcer | |
| CN101628053A (en) | Chinese herbal medicament used to treat painful swollen gum caused by intense stomach fire | |
| CN102755519B (en) | Kudzuvine root-kudzuvine flower anti-canker sore particle and preparation method thereof | |
| CN105878701A (en) | Traditional Chinese medicine composition for child coughing and preparing method thereof | |
| CN102727627B (en) | Traditional Chinese medicine composition for treating heart failure and preparation method and application thereof | |
| CN104000883B (en) | A kind of tablet for the treatment of gastritis and its preparation method and application | |
| CN101194945A (en) | Tablet for treating headache and method for preparing the same | |
| CN104435079A (en) | Traditional Chinese medicinal composition for treating gout | |
| CN103860911B (en) | A kind of pharmaceutical composition treating chronic renal failure and preparation method and purposes | |
| CN102772645B (en) | Traditional Chinese medicine for treating cold and preparation method thereof | |
| CN103919972B (en) | A kind of pharmaceutical composition of resisting fatigue and its preparation method and application | |
| CN104306528A (en) | Traditional Chinese medicine composition for curing gastritis and preparation method thereof as well as application thereof | |
| CN102258713A (en) | Chinese medicinal composition for preventing and treating metabolic diseases | |
| CN104800805A (en) | Medicine for treating frequent micturition | |
| CN104398683A (en) | Traditional Chinese medicine for treating constipation, preparation method and application thereof | |
| CN104958430A (en) | Traditional Chinese medicinal composition for treating chronic trachitis and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| ASS | Succession or assignment of patent right |
Owner name: ZHANG FENGHUA Free format text: FORMER OWNER: NANJING ZHENGKUAN PHARMACEUTICAL SCIENCE AND TECHNOLOGY CO., LTD. Effective date: 20140714 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| C53 | Correction of patent for invention or patent application | ||
| CB03 | Change of inventor or designer information |
Inventor after: Zhang Fenghua Inventor before: The inventor has waived the right to be mentioned |
|
| COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 211224 NANJING, JIANGSU PROVINCE TO: 266000 QINGDAO, SHANDONG PROVINCE Free format text: CORRECT: INVENTOR; FROM: REQUEST NOT TO RELEASE THE NAME TO: ZHANG FENGHUA |
|
| TA01 | Transfer of patent application right |
Effective date of registration: 20140714 Address after: Shinan District 266000 Shandong city of Qingdao province Ningxia road 293, building 2, unit 1, 203 households Applicant after: Zhang Fenghua Address before: 211224 No. 1 Industrial Park, Jing Qiao Town, Lishui County, Jiangsu, Nanjing Applicant before: Nanjing Zhengkuan Pharmaceutical Science and Technology Co., Ltd. |
|
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20140820 Termination date: 20151208 |
|
| EXPY | Termination of patent right or utility model |